Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Abroad (travel likely)RecruitingPHASE1
Conditions
Cervical Cancer · Breast Cancer · Colon Cancer · NSCLC · mCRPC (Metastatic Castration-resistant Prostate Cancer) · Glioblastoma · Nonsmall Cell Lung Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Northwestern University Robert H Lurie Medical Research, Chicago, Illinois, United States
UK Markey Cancer Center, Lexington, Kentucky, United States
Contact: Principal Investigator (Eddy Yang, MD)Advanced Molecular Imaging and Therapy, Glen Burnie, Maryland, United States
Contact: Principal Investigator (Michael Morris, MD)XCancer Omaha / Urology Cancer Center, Omaha, Nebraska, United States
Contact: Principal Investigator (Luke Nordquist, MD)